Jennifer Lew
Director of Finance/CFO bij ANNEXON, INC.
Vermogen: 457 063 $ op 29-02-2024
Profiel
Presently, Jennifer Lew is Chief Financial Officer & Executive Vice President for Annexon, Inc. Ms. Lew is also on the board of Boundless Bio, Inc.
In her past career she was VP, Chief Financial & Accounting Officer at Dynavax Technologies Corp., Finance Director & Assistant Controller at QRS Corp., Chief Financial & Accounting Officer at Aduro BioTech, Inc. and Audit Manager at Ernst & Young LLP.
Jennifer Lew received an undergraduate degree from Claremont McKenna College.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ANNEXON, INC.
0.10% | 20-02-2024 | 82 058 ( 0.10% ) | 457 063 $ | 29-02-2024 |
Boundless Bio, Inc.
Boundless Bio, Inc. BiotechnologyHealth Technology Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA. -.--% | 15-02-2024 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Jennifer Lew
Bedrijven | Functie | Begin |
---|---|---|
ANNEXON, INC. | Director of Finance/CFO | 01-06-2019 |
Boundless Bio, Inc.
Boundless Bio, Inc. BiotechnologyHealth Technology Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA. | Director/Board Member | 05-01-2022 |
Eerdere bekende functies van Jennifer Lew
Bedrijven | Functie | Einde |
---|---|---|
CHINOOK THERAPEUTICS, INC. | Director of Finance/CFO | 24-05-2019 |
DYNAVAX TECHNOLOGIES CORPORATION | Director of Finance/CFO | 15-10-2013 |
QRS Corp.
QRS Corp. Internet Software/ServicesTechnology Services QRS Corp. provide electronic commerce merchandising and logistics solutions. The services include catalog services, network services, inventory management services, logistics management services and professional services. The company is headquartered in Richmond, CA. | Director of Finance/CFO | 01-01-2004 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01-01-1999 |
Opleiding van Jennifer Lew
Claremont McKenna College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
ANNEXON, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
QRS Corp.
QRS Corp. Internet Software/ServicesTechnology Services QRS Corp. provide electronic commerce merchandising and logistics solutions. The services include catalog services, network services, inventory management services, logistics management services and professional services. The company is headquartered in Richmond, CA. | Technology Services |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
Boundless Bio, Inc.
Boundless Bio, Inc. BiotechnologyHealth Technology Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA. | Health Technology |